The Board of Directors approved the allotment via Circular Resolution passed on October 12, 2026, based on the recommendation of the Nomination and Remuneration Committee.
Allotment Details
- Number of Equity Shares allotted: 43,155
- Face value per share: ₹10
- Date of issue: October 12, 2026
- Distinctive number range: 4,35,23,073 to 4,35,66,227
Exercise Price Details
- 19,155 Equity Shares exercised at ₹804 per share
- 24,000 Equity Shares exercised at ₹1,124 per share
Premium Calculation
- Premium of ₹794 per share for 19,155 Equity Shares (exercise price ₹804 minus face value ₹10)
- Premium of ₹1,114 per share for 24,000 Equity Shares (exercise price ₹1,124 minus face value ₹10)
Capital Structure Impact
- Total issued shares after this issue: 4,35,66,227
- Total issued share capital after this issue: ₹43,56,62,270
- The shares issued upon exercise are freely transferable and not subject to any lock-in restrictions, except as required under applicable laws
- All equity shares allotted rank pari-passu with existing equity shares of the company
Additional Information
- No share certificate numbers applicable (demat issuance)
- No listing fees payable
- Information available on company website: www.enterohealthcare.com
Signed by Sanu Kapoor, Vice President – Group General Counsel, Company Secretary & Compliance Officer on October 12, 2026.